D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Emerson Electric
EMR
|
+$577M |
| 2 |
Amazon
AMZN
|
+$538M |
| 3 |
Tesla
TSLA
|
+$501M |
| 4 |
Netflix
NFLX
|
+$352M |
| 5 |
Adobe
ADBE
|
+$342M |
Top Sells
| 1 |
Alibaba
BABA
|
+$945M |
| 2 |
NVIDIA
NVDA
|
+$485M |
| 3 |
CELG
Celgene Corp
CELG
|
+$460M |
| 4 |
ConocoPhillips
COP
|
+$344M |
| 5 |
Biogen
BIIB
|
+$322M |
Sector Composition
| 1 | Technology | 20.59% |
| 2 | Consumer Discretionary | 15.86% |
| 3 | Healthcare | 13.39% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
COHR
1376
DELISTED
Coherent Inc
COHR
| $2.98M | ﹤0.01% |
+17,936
| New | +$2.98M |
|
1377
Ball Corp
BALL
$13.9B
| $2.97M | ﹤0.01% |
45,969
+8,322
| +22% | +$538K |
|
1378
Lincoln National
LNC
$8.05B
| $2.97M | ﹤0.01% |
+50,326
| New | +$2.97M |
|
1379
Eventbrite
EB
$265M
| $2.96M | ﹤0.01% |
146,731
+126,286
| +618% | +$2.55M |
|
|
ARQL
1380
DELISTED
Arqule Inc
ARQL
| $2.95M | ﹤0.01% |
+147,664
| New | +$2.95M |
|
|
INFN
1381
DELISTED
Infinera Corporation Common Stock
INFN
| $2.94M | ﹤0.01% |
370,597
+31,467
| +9% | +$250K |
|
|
BDN
1382
Brandywine Realty Trust
BDN
$782M
| $2.93M | ﹤0.01% |
186,111
-184,324
| -50% | -$2.9M |
|
1383
Assembly Biosciences
ASMB
$168M
| $2.93M | ﹤0.01% |
11,924
-8,132
| -41% | -$2M |
|
1384
VanEck Gold Miners ETF
GDX
$21B
| $2.93M | ﹤0.01% |
100,000
| – | – |
|
1385
Bain Capital Specialty
BCSF
$1B
| $2.93M | ﹤0.01% |
+150,911
| New | +$2.93M |
|
1386
Liberty Latin America Class A
LILA
$1.5B
| $2.92M | ﹤0.01% |
160,322
-5,681
| -3% | -$103K |
|
1387
SunCoke Energy
SXC
$652M
| $2.91M | ﹤0.01% |
467,281
+8,675
| +2% | +$54.1K |
|
1388
Sasol
SSL
$4.48B
| $2.9M | ﹤0.01% |
134,003
+9,947
| +8% | +$215K |
|
1389
Prologis
PLD
$107B
| $2.89M | ﹤0.01% |
32,443
-20,168
| -38% | -$1.8M |
|
1390
Cytokinetics
CYTK
$6.24B
| $2.89M | ﹤0.01% |
272,550
+232,113
| +574% | +$2.46M |
|
1391
Entravision Communication
EVC
$217M
| $2.88M | ﹤0.01% |
1,099,787
+65,535
| +6% | +$172K |
|
1392
First Bancorp
FBNC
$2.29B
| $2.87M | ﹤0.01% |
72,028
-1,494
| -2% | -$59.6K |
|
1393
Esperion Therapeutics
ESPR
$563M
| $2.86M | ﹤0.01% |
47,975
+17,885
| +59% | +$1.07M |
|
|
THCBU
1394
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $2.86M | ﹤0.01% |
272,120
| – | – |
|
1395
Church & Dwight Co
CHD
$22.8B
| $2.85M | ﹤0.01% |
40,463
-1,547
| -4% | -$109K |
|
|
CAI
1396
DELISTED
CAI International, Inc.
CAI
| $2.84M | ﹤0.01% |
98,120
-15,262
| -13% | -$442K |
|
1397
Center Bancorp
CNOB
$1.27B
| $2.83M | ﹤0.01% |
109,874
-1,138
| -1% | -$29.3K |
|
|
AKCA
1398
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $2.83M | ﹤0.01% |
166,789
+109,992
| +194% | +$1.86M |
|
1399
REV Group
REVG
$3.09B
| $2.82M | ﹤0.01% |
230,635
+192,949
| +512% | +$2.36M |
|
1400
Fresenius Medical Care
FMS
$14.7B
| $2.81M | ﹤0.01% |
76,405
+68,731
| +896% | +$2.53M |
|